메뉴 건너뛰기




Volumn 135, Issue 2, 2009, Pages 227-234

Bendamustine, but not fludarabine, exhibits a low stem cell toxicity in vitro

Author keywords

Apoptosis; Bendamustine; Clonogenic; Fludarabine; Stem cell toxicity

Indexed keywords

ANTINEOPLASTIC AGENT; BENDAMUSTINE; CHLORMETHINE DERIVATIVE; DRUG DERIVATIVE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; VIDARABINE;

EID: 65849476211     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-008-0453-8     Document Type: Article
Times cited : (21)

References (34)
  • 1
    • 0030973344 scopus 로고    scopus 로고
    • Fludarabine. An update of its pharmacology and use in the treatment of haematological malignancies
    • Adkins JC, Peters DH, Markham A (1997) Fludarabine. An update of its pharmacology and use in the treatment of haematological malignancies. Drugs 53:1005-1037
    • (1997) Drugs , vol.53 , pp. 1005-1037
    • Adkins, J.C.1    Peters, D.H.2    Markham, A.3
  • 2
    • 0034995976 scopus 로고    scopus 로고
    • Bendamustine
    • Balfour JA, Goa KL (2001) Bendamustine. Drugs 61:631-640
    • (2001) Drugs , vol.61 , pp. 631-640
    • Balfour, J.A.1    Goa, K.L.2
  • 3
    • 2342467469 scopus 로고    scopus 로고
    • Prospective strategies to enforce selectively cell death in cancer cells
    • Blagosklonny MV (2004) Prospective strategies to enforce selectively cell death in cancer cells. Oncogene 23:2967-2975
    • (2004) Oncogene , vol.23 , pp. 2967-2975
    • Blagosklonny, M.V.1
  • 5
    • 0037099675 scopus 로고    scopus 로고
    • Late activation of apoptotic pathways plays a negligible role in mediating the cytotoxic effects of discodermolide and epothilone B in non-small cell lung cancer cells
    • Bröker LE, Huisman C, Ferreira CG, Rodriguez JA, Kruyt FA, Giaccone G (2002) Late activation of apoptotic pathways plays a negligible role in mediating the cytotoxic effects of discodermolide and epothilone B in non-small cell lung cancer cells. Cancer Res 62:4081-4088
    • (2002) Cancer Res , vol.62 , pp. 4081-4088
    • Bröker, L.E.1    Huisman, C.2    Ferreira, C.G.3    Rodriguez, J.A.4    Kruyt, F.A.5    Giaccone, G.6
  • 6
    • 0037039381 scopus 로고    scopus 로고
    • Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent
    • Chang BD, Swift ME, Shen M, Fang J, Broude EV, Roninson IB (2002) Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent. Proc Natl Acad Sci USA 99:389-394
    • (2002) Proc Natl Acad Sci USA , vol.99 , pp. 389-394
    • Chang, B.D.1    Swift, M.E.2    Shen, M.3    Fang, J.4    Broude, E.V.5    Roninson, I.B.6
  • 7
    • 0035351214 scopus 로고    scopus 로고
    • In vitro induction of apoptosis of neoplastic cells in low-grade non-Hodgkin's lymphomas using combinations of established cytotoxic drugs with bendamustine
    • Chow KU, Boehrer S, Geduldig K, Krapohl A, Hoelzer D, Mitrou PS, Weidmann E (2001) In vitro induction of apoptosis of neoplastic cells in low-grade non-Hodgkin's lymphomas using combinations of established cytotoxic drugs with bendamustine. Haematologica 86:485-493
    • (2001) Haematologica , vol.86 , pp. 485-493
    • Chow, K.U.1    Boehrer, S.2    Geduldig, K.3    Krapohl, A.4    Hoelzer, D.5    Mitrou, P.S.6    Weidmann, E.7
  • 8
    • 0036334046 scopus 로고    scopus 로고
    • Bendamustine in the treatment of hematologic malignancies. Introduction
    • Diehl V, Cheson BD (2002) Bendamustine in the treatment of hematologic malignancies. Introduction. Semin Oncol 29:1-3
    • (2002) Semin Oncol , vol.29 , pp. 1-3
    • Diehl, V.1    Cheson, B.D.2
  • 9
    • 0032949451 scopus 로고    scopus 로고
    • Pharmacokinetic study of single doses of oral fludarabine phosphate in patients with "low-grade" non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia
    • Foran JM, Oscier D, Orchard J, Johnson SA, Tighe M, Cullen MH, de Takats PG, Kraus C, Klein M, Lister TA (1999) Pharmacokinetic study of single doses of oral fludarabine phosphate in patients with "low-grade" non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia. J Clin Oncol 17:1574-1579
    • (1999) J Clin Oncol , vol.17 , pp. 1574-1579
    • Foran, J.M.1    Oscier, D.2    Orchard, J.3    Johnson, S.A.4    Tighe, M.5    Cullen, M.H.6    De Takats, P.G.7    Kraus, C.8    Klein, M.9    Lister, T.A.10
  • 10
    • 0036340122 scopus 로고    scopus 로고
    • Metabolism and mechanisms of action of bendamustine: Rationales for combination therapies
    • Gandhi V (2002) Metabolism and mechanisms of action of bendamustine: rationales for combination therapies. Semin Oncol 29:4-11
    • (2002) Semin Oncol , vol.29 , pp. 4-11
    • Gandhi, V.1
  • 11
    • 0036204648 scopus 로고    scopus 로고
    • Cellular and clinical pharmacology of fludarabine
    • Gandhi V, Plunkett W (2002) Cellular and clinical pharmacology of fludarabine. Clin Pharmacokinet 41:93-103
    • (2002) Clin Pharmacokinet , vol.41 , pp. 93-103
    • Gandhi, V.1    Plunkett, W.2
  • 12
    • 0027202081 scopus 로고
    • Cellular pharmacology of fludarabine triphosphate in chronic lymphocytic leukemia cells during fludarabine therapy
    • Gandhi V, Kemena A, Keating MJ, Plunkett W (1993) Cellular pharmacology of fludarabine triphosphate in chronic lymphocytic leukemia cells during fludarabine therapy. Leuk Lymphoma 10:49-56
    • (1993) Leuk Lymphoma , vol.10 , pp. 49-56
    • Gandhi, V.1    Kemena, A.2    Keating, M.J.3    Plunkett, W.4
  • 13
    • 33645744086 scopus 로고    scopus 로고
    • Lymphomas are sensitive to perforin-dependent cytotoxic pathways despite expression of PI-9 and overexpression of bcl-2
    • Godal R, Keilholz U, Uharek L, Letsch A, Asemissen AM, Busse A, Na IK, Thiel E, Scheibenbogen C (2006) Lymphomas are sensitive to perforin-dependent cytotoxic pathways despite expression of PI-9 and overexpression of bcl-2. Blood 107:3205-3211
    • (2006) Blood , vol.107 , pp. 3205-3211
    • Godal, R.1    Keilholz, U.2    Uharek, L.3    Letsch, A.4    Asemissen, A.M.5    Busse, A.6    Na, I.K.7    Thiel, E.8    Scheibenbogen, C.9
  • 14
    • 34247177620 scopus 로고    scopus 로고
    • A mathematical approach to study combined effects of toxicants in vitro: Evaluation of the Bliss independence criterion and the Loewe additivity model
    • Goldoni M, Johansson C (2007) A mathematical approach to study combined effects of toxicants in vitro: evaluation of the Bliss independence criterion and the Loewe additivity model. Toxicol In Vitro 21:759-769
    • (2007) Toxicol in Vitro , vol.21 , pp. 759-769
    • Goldoni, M.1    Johansson, C.2
  • 15
    • 0142227045 scopus 로고    scopus 로고
    • In vitro toxicity of three new antitumoral drugs (trabectedin, aplidin, and kahalalide F) on hematopoietic progenitors and stem cells
    • Gómez SG, Bueren JA, Faircloth GT, Jimeno J, Albella B (2003) In vitro toxicity of three new antitumoral drugs (trabectedin, aplidin, and kahalalide F) on hematopoietic progenitors and stem cells. Exp Hematol 31:1104-1111
    • (2003) Exp Hematol , vol.31 , pp. 1104-1111
    • Gómez, S.G.1    Bueren, J.A.2    Faircloth, G.T.3    Jimeno, J.4    Albella, B.5
  • 22
    • 31344443373 scopus 로고    scopus 로고
    • Treatment of bendamustine and prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with melphalan and prednisone-a randomized phase III study of the East German Study Group of Hematology and Oncology (OSHO)
    • Pönisch W, Mitrou PS, Merkle K, Herold M, Assmann M, Wilhelm G, Dachselt K, Richter P, Schirmer V, Schulze A, Subert R, Harksel B, Grobe N, Stelzer E, Schulze M, Bittrich A, Freund M, Pasold R, Friedrich T, Helbig W, Niederwieser D, East German Study Group of Hematology, Oncology (OSHO) (2006) Treatment of bendamustine and prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with melphalan and prednisone-a randomized phase III study of the East German Study Group of Hematology and Oncology (OSHO). J Cancer Res Clin Oncol 132:205-212
    • (2006) J Cancer Res Clin Oncol , vol.132 , pp. 205-212
    • Pönisch, W.1    Mitrou, P.S.2    Merkle, K.3    Herold, M.4    Assmann, M.5    Wilhelm, G.6    Dachselt, K.7    Richter, P.8    Schirmer, V.9    Schulze, A.10    Subert, R.11    Harksel, B.12    Grobe, N.13    Stelzer, E.14    Schulze, M.15    Bittrich, A.16    Freund, M.17    Pasold, R.18    Friedrich, T.19    Helbig, W.20    more..
  • 23
  • 24
    • 0037224796 scopus 로고    scopus 로고
    • Effects of amifostine on clonogenic mesenchymal progenitors and hematopoietic progenitors exposed to radiation
    • Ramdas J, Warrier RP, Scher C, Larussa V (2003) Effects of amifostine on clonogenic mesenchymal progenitors and hematopoietic progenitors exposed to radiation. J Pediatr Hematol Oncol 25:19-26
    • (2003) J Pediatr Hematol Oncol , vol.25 , pp. 19-26
    • Ramdas, J.1    Warrier, R.P.2    Scher, C.3    Larussa, V.4
  • 26
    • 0038277105 scopus 로고    scopus 로고
    • Tumor cell senescence in cancer treatment
    • Roninson IB (2003) Tumor cell senescence in cancer treatment. Cancer Res 63:2705-2715
    • (2003) Cancer Res , vol.63 , pp. 2705-2715
    • Roninson, I.B.1
  • 27
    • 0036340530 scopus 로고    scopus 로고
    • In vitro studies with bendamustine: Enhanced activity in combination with rituximab
    • Rummel MJ, Chow KU, Hoelzer D, Mitrou PS, Weidmann E (2002) In vitro studies with bendamustine: enhanced activity in combination with rituximab. Semin Oncol 29:12-14
    • (2002) Semin Oncol , vol.29 , pp. 12-14
    • Rummel, M.J.1    Chow, K.U.2    Hoelzer, D.3    Mitrou, P.S.4    Weidmann, E.5
  • 29
    • 0036340334 scopus 로고    scopus 로고
    • Phase i studies with bendamustine: An update
    • Schrijvers D, Vermorken JB (2002) Phase I studies with bendamustine: an update. Semin Oncol 29:15-18
    • (2002) Semin Oncol , vol.29 , pp. 15-18
    • Schrijvers, D.1    Vermorken, J.B.2
  • 32
    • 0038359609 scopus 로고    scopus 로고
    • Myeloid clonogenic assays for comparison of the in vitro toxicity of alkylating agents
    • Volpe DA, Warren MK (2003) Myeloid clonogenic assays for comparison of the in vitro toxicity of alkylating agents. Toxicol In Vitro 17:271-277
    • (2003) Toxicol in Vitro , vol.17 , pp. 271-277
    • Volpe, D.A.1    Warren, M.K.2
  • 33
    • 24044442891 scopus 로고    scopus 로고
    • Bendamustine prolongs progression-free survival in metastatic breast cancer (MBC): A phase III prospective, randomized, multicenter trial of bendamustine hydrochloride, methotrexate and 5-fluorouracil (BMF) versus cyclophosphamide, methotrexate and 5-fluorouracil (CMF) as first-line treatment of MBC
    • Von Minckwitz G, Chernozemsky I, Sirakova L, Chilingirov P, Souchon R, Marschner N, Kleeberg U, Tsekov C, Fritze D, Thomssen C, Stuart N, Vermorken JB, Loibl S, Merkle KH, Kaufmann M (2005) Bendamustine prolongs progression-free survival in metastatic breast cancer (MBC): a phase III prospective, randomized, multicenter trial of bendamustine hydrochloride, methotrexate and 5-fluorouracil (BMF) versus cyclophosphamide, methotrexate and 5-fluorouracil (CMF) as first-line treatment of MBC. Anticancer Drugs 16:871-877
    • (2005) Anticancer Drugs , vol.16 , pp. 871-877
    • Von Minckwitz, G.1    Chernozemsky, I.2    Sirakova, L.3    Chilingirov, P.4    Souchon, R.5    Marschner, N.6    Kleeberg, U.7    Tsekov, C.8    Fritze, D.9    Thomssen, C.10    Stuart, N.11    Vermorken, J.B.12    Loibl, S.13    Merkle, K.H.14    Kaufmann, M.15


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.